Savant Capital LLC Boosts Stock Position in HCA Healthcare, Inc. $HCA

by · The Cerbat Gem

Savant Capital LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 15.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,302 shares of the company’s stock after purchasing an additional 444 shares during the period. Savant Capital LLC’s holdings in HCA Healthcare were worth $1,265,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Park Place Capital Corp boosted its position in HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Harrell Investment Partners LLC lifted its position in HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after buying an additional 1,158 shares during the period. Simon Quick Advisors LLC grew its position in shares of HCA Healthcare by 616.9% in the 2nd quarter. Simon Quick Advisors LLC now owns 7,147 shares of the company’s stock worth $2,738,000 after buying an additional 6,150 shares during the period. Finally, Simplicity Wealth LLC boosted its stake in HCA Healthcare by 92.7% during the second quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock worth $689,000 after acquiring an additional 865 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $474.08 on Thursday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $479.43. The stock’s fifty day moving average price is $431.29 and its 200-day moving average price is $394.54. The company has a market cap of $108.18 billion, a P/E ratio of 18.33, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. Stephens upped their price target on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Bank of America upped their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Morgan Stanley set a $425.00 target price on shares of HCA Healthcare in a report on Monday, October 27th. KeyCorp boosted their price objective on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Finally, Cowen reissued a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $473.53.

Check Out Our Latest Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).